EP Lab Digest - March 2008 - (Page 25)

MARCH 2008 EP RESEARCH 25 Trial End Date: December 2008 Status: Recruiting Purpose: The purpose of this longitudinal, prospective study is the identification of familial congenital arrhythmogenic disorders and their clinical follow-up. Contact: Christian Wolpert, MD, christian.wolper t@med.ma.uniheidelberg.de, Rainer Schimpf, MD, rainer.schimpf@med.ma.uni-heidelberg.de Premature Ventricular Complexes Title: Relativity Study Between Idiopathic Ventricular Arrhythmia and Sex Hormone Levels in Different Stages of Menstrual Cycle Number of Patients: 40 Trial Start Date: January 2008 Trial End Date: December 2008 Status: Recruiting Purpose: The purpose of this observational, prospective study is to determine whether the occurrence of the idiopathic right ventricular outflow tract (RVOT) arrhythmia is relative to sex hormone levels in different stages of the female menstrual cycle. Contact: Xiaopeng Bai, Principal Investigator, bxp007@163.com, Xueqi Li, lixueqi@medmail.com.cn With ICDs Number of Patients: 5,000 Trial Start Date: October 2007 Trial End Date: April 2011 Purpose: This study will randomize patients with CHD and an ejection fraction between 30–40% to ICD therapy versus no ICD therapy. The primary outcome is mortality, and the Sudden Cardiac Death Title: Selective Strategy to Manage Arrhythmia Risk and Therapy See CLINICAL TRIALS page 26 Long QT Syndrome Title: The Long QT Syndrome in Pregnancy Number of Patients: 12 Trial Start Date: June 2007 Trial End Date: June 2008 Purpose: Our aim is to study as many women who have had a baby who have the long QT syndrome (LQTS) to give us a better idea of whether there are any arrhythmias occurring at the time of delivery.This study will be a retrospective analysis of all LQTS women managed at St. Paul’s or BC Women’s Hospital who have been pregnant in the last five years. Contact: Areta Wong Title: Pediatric Lead Extractability and Survival Evaluation (PLEASE) Study: A Prospective Assessment of Implantable Cardioverter Defibrillator (ICD) Lead Extractability and Survival in Children and Congenital Heart Disease Patients Number of Patients: 300 Trial Start Date: June 2006 Trial End Date: June 2011 Purpose: This is a randomized, prospective clinical trial comparing two different types of implantable cardioverter defibrillator (ICD) leads in children and patients with congenital heart disease. ICD lead survival in this patient group is particularly suboptimal, and lead extraction is technically difficult and carries a substantial morbidity risk. Recently, improved ICD lead designs have been released and are currently being utilized in patients. The main aim of the study is to determine if either type of lead performs better in terms of implantation electrical characteristics, long-term survival without breaking, and ease of extractability. Contact: Charles I. Berul, MD, Principal Investigator, Children's Hospital Boston, Frank Cecchin, MD http://www.carelinknetwork.com http://www.carelinknetwork.com

Table of Contents Feed for the Digital Edition of EP Lab Digest - March 2008

EP Lab Digest - March 2008 ECG 101: The Case of a Dizzy Patient with a Left Bundle Branch Block Delayed Defibrillation: Research and Results Interview with Paul S. Chan, MD Contents Letter from the Editor Spotlight Interview: St. Joseph’s Hospital Health Center Parent Heart Watch from 36,000 Feet… Perspectives from the Annual Leadership Conference Clinical Trial Overview: 2008 Are MRI-Safe Pacemakers and Leads on the Horizon? Q & A with J. Rod Gimbel, MD Navigating Tortuous Coronary Sinus Anatomy Using a Bipolar Lead Email Discussion Group: March 2008 Guidelines on ECG Interpretation Spotlight Interview Update: What Have We Learned? The Value of Educating Staff Events Calendar Industry News and Products Classifieds Advertisers Index In Memoriam

EP Lab Digest - March 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.